financetom
Business
financetom
/
Business
/
Blackstone in talks to buy stake in New York office building-sources
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Blackstone in talks to buy stake in New York office building-sources
Jan 30, 2025 10:45 AM

NEW YORK (Reuters) - Blackstone is in talks to buy a sizeable stake in a New York 50-story office building from institutional investors of JPMorgan Asset Management, two sources familiar with the matter said on Thursday.

The planned move comes as Blackstone executives signalled on an earnings call that the troubled commercial real estate sector was stabilizing.

The Manhattan building, 1345 Avenue of the Americas, is jointly owned by institutional investors advised by J.P. Morgan Global Alternatives and Fisher Brothers.

JPMorgan Asset has no equity interest in the building, which is partly owned by its institutional investors, one of the sources said.

Blackstone and JPMorgan Asset Management declined to comment. The sources declined to be named because the talks are not public.

In 2023 law firm Paul, Weiss, Rifkind, Wharton & Garrison LLP signed a 20-year, 765,000 square-foot lease, initially occupying 18 floors of the building, according to an announcement then.

Bloomberg News earlier reported Blackstone's talks to buy the building.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Centessa Pharmaceuticals Insider Sold Shares Worth $607,960, According to a Recent SEC Filing
Centessa Pharmaceuticals Insider Sold Shares Worth $607,960, According to a Recent SEC Filing
Mar 26, 2024
04:25 PM EDT, 03/26/2024 (MT Newswires) -- Karen M. Anderson, Chief People Officer, on March 25, 2024, sold 51,160 shares in Centessa Pharmaceuticals ( CNTA ) for $607,960. Following the Form 4 filing with the SEC, Anderson has control over a total of 71,525 shares of the company, with 71,525 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1847903/000184790324000046/xslF345X03/wk-form4_1711484173.xml ...
Rocket Pharmaceuticals Appoints Aaron Ondrey as CFO
Rocket Pharmaceuticals Appoints Aaron Ondrey as CFO
Mar 26, 2024
04:24 PM EDT, 03/26/2024 (MT Newswires) -- Rocket Pharmaceuticals ( RCKT ) said Tuesday it has appointed Aaron Ondrey as chief financial officer. Ondrey most recently served as CFO of Mirati Therapeutics. ...
Pioneer Natural Resources Insider Sold Shares Worth $1,105,248, According to a Recent SEC Filing
Pioneer Natural Resources Insider Sold Shares Worth $1,105,248, According to a Recent SEC Filing
Mar 26, 2024
04:24 PM EDT, 03/26/2024 (MT Newswires) -- Mark H Kleinman, Executive Vice President & General Counsel, on March 22, 2024, sold 4,350 shares in Pioneer Natural Resources ( PXD ) for $1,105,248. Following the Form 4 filing with the SEC, Kleinman has control over a total of 45,506 shares of the company, with 45,506 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1038357/000103835724000035/xslF345X03/wk-form4_1711484348.xml...
Kkr Fs Income Trust Select Insider Bought Shares Worth $11,428,571, According to a Recent SEC Filing
Kkr Fs Income Trust Select Insider Bought Shares Worth $11,428,571, According to a Recent SEC Filing
Mar 26, 2024
04:25 PM EDT, 03/26/2024 (MT Newswires) -- Michael C. Forman, 10% Owner, Director, President & CEO, on March 26, 2024, executed a purchase for 457,143 shares in Kkr Fs Income Trust Select (NONE) for $11,428,571. Following the Form 4 filing with the SEC, Forman has control over a total of 400,315 shares of the company, with 400,315 controlled indirectly. SEC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved